Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3344816 | 0.86 | CYP2C19 (0.56) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL6932662 | 0.83 | CYP2C19 (0.61) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL9698823 | 0.82 | TSHR (0.53) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL7693596 | 0.82 | TSHR (0.53) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL76204 | 0.82 | CYP2C19 (0.64) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| Silver SCHEMBL11309103 | 0.82 | CYP2C19 (0.59) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL30643815 | 0.82 | CYP2C19 (0.64) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL3089874 | 0.82 | CYP2C19 (0.59) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL1369962 | 0.82 | CYP2C19 (0.59) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 | |
| SCHEMBL3014336 | 0.81 | CYP2C19 (0.54) | CYP2C19CYP1A2ALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114031502-A | Preparation method of p-nitroacetophenone | 南京一苇医药科技有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-107089954-B | Method for synthesizing aminoquinoxaline mixtures | 常州市阳光药业有限公司 | 2020-04-24 | — | — | CN | claimed |
| CN-107089954-A | The method of synthesizing amino quinoxaline mixture | 常州市阳光药业有限公司 | 2017-08-25 | — | — | CN | claimed |
| EP-1727550-B1 | PHARMACEUTICAL COMPOSITION COMPRISING A BENZODIAZEPINE DERIVATIVE AND AN INHIBITOR OF THE RSV FUSION PROTEIN | ARROW THERAPEUTICS LTD (GB) | 2009-07-29 | — | — | EP | claimed |
| US-12404249-B2 | Heterocyclic derivatives and use thereof | C&C RESEARCH LABORATORIES (KR) | 2025-09-02 | — | — | US | disclosed |
| EP-3802495-B1 | 4-(2-((2-CHLOROQUINOLIN-4-YL)AMINO)ETHYL)BENZENESULFONAMIDE DERIVATIVES AS STAT3 INHIBITORS FOR THE TREATMENT OF CANCER | C&C RES LAB (KR) | 2025-07-02 | — | — | EP | disclosed |
| US-12258321-B1 | Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer | University of Jeddah (SA) | 2025-03-25 | — | — | US | disclosed |
| CN-119241469-A | Photoinitiator, photopolymerization composition and application thereof | 武汉尚赛光电科技有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-118271195-A | Liquid crystal-like diamine monomer and preparation method thereof, modified polyimide and preparation method thereof | 先丰通讯股份有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-115710202-B | Preparation method and application of apataone key intermediate | 江西同和药业股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-112204010-B | Heterocyclic derivatives and uses thereof | C&C新药研究所 | 2024-03-19 | — | — | CN | disclosed |
| US-20230287005-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. | 2023-09-14 | — | — | US | disclosed |
| US-4029669-A | 6-Benzalimino-6-arylthio penicillanic acids and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1977-06-14 | — | — | US | disclosed |
| US-4029806-A | Nitro-β-lactam antibiotics and processes for their preparation and use | BAYER AKTIENGESELLSCHAFT (DT) | 1977-06-14 | — | — | US | disclosed |
| US-4026886-A | 7-Acyl-7-arylthiocephalosporins | E. R. SQUIBB & SONS, INC. (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026709-A | Color photographic recording material | CIBA-GEIGY AG (CH) | 1977-05-31 | — | — | US | disclosed |
| US-4012518-A | PENICILLIN DERIVATIVES AS GROWTH AND FEED UTILIZATION PROMOTERS IN ANIMALS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-15 | — | — | US | disclosed |
| US-3984432-A | PHOSPHONIC ACID AND PHOSPHORIC ACID DERIVATIVES | CIBA-GEIGY AG (CH) | 1976-10-05 | — | — | US | disclosed |
| US-3965093-A | 6-Arylthio penicillanic acid and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1976-06-22 | — | — | US | disclosed |
| US-3954744-A | ANTIBACTERIAL | E. R. SQUIBB & SONS, INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287005-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | CFD, F12, F3 | CYP2C19 66/4885CYP1A2 110/4885ALDH1A1 1847/4885 |
| US-12404249-B2 | Heterocyclic derivatives and use thereof | STAT3, JAK2, IRF3 | CYP2C19 3889/4885CYP1A2 4198/4885ALDH1A1 1899/4885 |
| US-12258321-B1 | Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer | MCL1, BCL2, BCL2A1 | CYP2C19 369/4885CYP1A2 256/4885ALDH1A1 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.